Gregory et al. [42] showed that when glutamine metabolism is restricted or hindered by a small molecule glutaminase inhibitor (CB-839) in a FLT-3 mutated AML in vitro model, cellular proliferation, mitochondrial respiration, and GSH production are all negatively affected. Here, FLT3 is linked to acute myeloid leukemia.